These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 10222059

  • 1. Differential impact of T cell repertoire diversity in diabetes-prone or -resistant IL-10 transgenic mice.
    Balasa B, Lee J, Sarvetnick N.
    Cell Immunol; 1999 May 01; 193(2):170-8. PubMed ID: 10222059
    [Abstract] [Full Text] [Related]

  • 2. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H, Lieu YK, Noorchashm N, Rostami SY, Greeley SA, Schlachterman A, Song HK, Noto LE, Jevnikar AM, Barker CF, Naji A.
    J Immunol; 1999 Jul 15; 163(2):743-50. PubMed ID: 10395666
    [Abstract] [Full Text] [Related]

  • 3. The microbial product lipopolysaccharide confers diabetogenic potential on the T cell repertoire of BDC2.5/NOD mice: implications for the etiology of autoimmune diabetes.
    Balasa B, Van Gunst K, Sarvetnick N.
    Clin Immunol; 2000 May 15; 95(2):93-8. PubMed ID: 10779402
    [Abstract] [Full Text] [Related]

  • 4. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS, Balasa B, Davies JD, Sarvetnick N.
    J Immunol; 1999 Aug 01; 163(3):1696-703. PubMed ID: 10415077
    [Abstract] [Full Text] [Related]

  • 5. Acceleration of spontaneous diabetes in TCR-beta-transgenic nonobese diabetic mice by beta-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-alpha chains.
    Verdaguer J, Yoon JW, Anderson B, Averill N, Utsugi T, Park BJ, Santamaria P.
    J Immunol; 1996 Nov 15; 157(10):4726-35. PubMed ID: 8906855
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice.
    Kim S, Kim HS, Chung KW, Oh SH, Yun JW, Im SH, Lee MK, Kim KW, Lee MS.
    Diabetes; 2007 Oct 15; 56(10):2561-8. PubMed ID: 17620422
    [Abstract] [Full Text] [Related]

  • 9. Molecular analysis of the T-cell receptor V beta 5 and V beta 8 repertoire in pancreatic lesions of autoimmune diabetic NOD mice.
    Berschick P, Fehsel K, Weltzien HU, Kolb H.
    J Autoimmun; 1993 Aug 15; 6(4):405-22. PubMed ID: 8216686
    [Abstract] [Full Text] [Related]

  • 10. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
    Li L, He Q, Garland A, Yi Z, Aybar LT, Kepler TB, Frelinger JA, Wang B, Tisch R.
    J Immunol; 2009 Dec 01; 183(11):7585-91. PubMed ID: 19917704
    [Abstract] [Full Text] [Related]

  • 11. RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice.
    Kay TW, Parker JL, Stephens LA, Thomas HE, Allison J.
    J Immunol; 1996 Oct 15; 157(8):3688-93. PubMed ID: 8871671
    [Abstract] [Full Text] [Related]

  • 12. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
    Ott PA, Anderson MR, Tary-Lehmann M, Lehmann PV.
    Cell Immunol; 2005 May 15; 235(1):1-11. PubMed ID: 16122720
    [Abstract] [Full Text] [Related]

  • 13. IL-10 impacts autoimmune diabetes via a CD8+ T cell pathway circumventing the requirement for CD4+ T and B lymphocytes.
    Balasa B, Davies JD, Lee J, Good A, Yeung BT, Sarvetnick N.
    J Immunol; 1998 Oct 15; 161(8):4420-7. PubMed ID: 9780221
    [Abstract] [Full Text] [Related]

  • 14. Protection against diabetes by MHC heterozygosity and reversal by cyclophosphamide.
    Wu AY, Schulman SJ, Marconi LA, Reilly CR, Scott B, Lo D.
    Cell Immunol; 1998 Mar 15; 184(2):112-20. PubMed ID: 9630837
    [Abstract] [Full Text] [Related]

  • 15. Dissimilar background genes control susceptibility to autoimmune disease in the context of different MHC haplotypes: NOD.H-2(s) congenic mice are relatively resistant to both experimental autoimmune encephalomyelitis and type I diabetes.
    Greve B, Reddy J, Waldner HP, Sobel RA, Kuchroo VK.
    Eur J Immunol; 2004 Jul 15; 34(7):1828-38. PubMed ID: 15214031
    [Abstract] [Full Text] [Related]

  • 16. Genetic requirements for acceleration of diabetes in non-obese diabetic mice expressing interleukin-2 in islet beta-cells.
    Allison J, McClive P, Oxbrow L, Baxter A, Morahan G, Miller JF.
    Eur J Immunol; 1994 Oct 15; 24(10):2535-41. PubMed ID: 7925581
    [Abstract] [Full Text] [Related]

  • 17. Two mechanisms for the non-MHC-linked resistance to spontaneous autoimmunity.
    Verdaguer J, Amrani A, Anderson B, Schmidt D, Santamaria P.
    J Immunol; 1999 Apr 15; 162(8):4614-26. PubMed ID: 10202001
    [Abstract] [Full Text] [Related]

  • 18. The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes.
    Balasa B, Sarvetnick N.
    J Autoimmun; 1996 Apr 15; 9(2):283-6. PubMed ID: 8738975
    [Abstract] [Full Text] [Related]

  • 19. Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.
    You S, Slehoffer G, Barriot S, Bach JF, Chatenoud L.
    Proc Natl Acad Sci U S A; 2004 Oct 05; 101 Suppl 2(Suppl 2):14580-5. PubMed ID: 15340148
    [Abstract] [Full Text] [Related]

  • 20. Human LT-alpha-mediated resistance to autoimmune diabetes is induced in NOD, but not NOD-scid, mice and abrogated by IL-12.
    Miyaguchi S, Satoh J, Takahashi K, Sakata Y, Nakazawa T, Miyazaki J, Toyota T.
    Clin Immunol; 2001 Jan 05; 98(1):119-24. PubMed ID: 11141334
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.